Amerigen Finds Partner to Develop Cancer Drugs in the US and China

Amerigen Pharma signed a collaboration agreement with Stason Pharma to develop generic oral oncology drugs. Both companies are located in the US. But Amerigen has a China subsidiary, located in Suzhou. According to Amerigen’s business plan, the company develops drugs for both markets. More details.... Share this with colleagues:   var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});